Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
198P Effectiveness of lenvatinib in patients with unresectable hepatocellular carcinoma: A multicenter observational study in Japan — Namiki Izumi (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
198P Effectiveness of lenvatinib in patients with unresectable hepatocellular carcinoma: A multicenter observational study in Japan
Shared by
Masatoshi Kudo
198P Effectiveness of lenvatinib in patients with unresectable hepatocellular carcinoma: A multicenter observational study in Japan
Article
2023
en
Authors
+6 more
NI
Namiki Izumi
Masatoshi Kudo
KM
Kenta Motomura
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
A multicenter observational study of lenvatinib for unresectable hepatocellular carcinoma in Japan.
Namiki Izumi
,
Masatoshi Kudo
,
Kenta Motomura
,
Yoshitaka Inaba
,
Yoshio Katamura
,
Yasuteru Kondo
,
Kazuhisa Yabushita
,
Katsuaki Motoyoshi
,
Junji Furuse
Article
2023
Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan
Junji Furuse
,
Namiki Izumi
,
Kenta Motomura
,
Yoshitaka Inaba
,
Yoshio Katamura
,
Yasuteru Kondo
,
Kazuhisa Yabushita
,
Katsuaki Motoyoshi
,
Masatoshi Kudo
Article
2019
Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan
Masahiro Kobayashi
,
Masatoshi Kudo
,
Namiki Izumi
,
Shuichi Kaneko
,
Mie Azuma
,
Ronda Copher
,
Genevieve Meier
,
Janice Pan
,
Mika Ishii
,
Shunya Ikeda
Article
2018
PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Shunya Ikeda
,
Masatoshi Kudo
,
Namiki Izumi
,
Satoshi Kaneko
,
Masahiro Kobayashi
,
Mie Azuma
,
Ronda Copher
,
Suchin Virabhak
,
David Mitchell
,
Genevieve Meier
,
Mika Ishii
Article
2022
Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis
Toshifumi Tada
,
Takashi Kumada
,
Atsushi Hiraoka
,
Masashi Hirooka
,
Kazuya Kariyama
,
Joji Tani
,
Masanori Atsukawa
,
Koichi Takaguchi
,
Ei Itobayashi
,
Shinya Fukunishi
,
Kunihiko Tsuji
,
Toru Ishikawa
,
Kazuto Tajiri
,
Hironori Ochi
,
Satoshi Yasuda
,
Hidenori Toyoda
,
Takeshi Hatanaka
,
Satoru Kakizaki
,
Noritomo Shimada
,
Kazuhito Kawata
,
Takaaki Tanaka
,
Hideko Ohama
,
Kazuhiro Nouso
,
Asahiro Morishita
,
Akemi Tsutsui
,
Takuya Nagano
,
Norio Itokawa
,
Tomomi Okubo
,
Taeang Arai
,
Michitaka Imai
,
Atsushi Naganuma
,
Tomoko Aoki
,
Yohei Koizumi
,
Shinichiro Nakamura
,
Kouji Joko
,
Yoichi Hiasa
,
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.